Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be ...

Chronic Obstructive Pulmonary Disease, or COPD, is a serious condition that affects the lungs, making it hard to breathe. It develops slowly over time and is often caused by damage to the airways and ...

Blood levels of two markers may help predict treatment response and outcomes in pulmonary arterial hypertension patients, per ...

Cardiopulmonary assessment tool detects and monitors digital biomarkers to support health management and help improve ...

The editor’s pick for this issue is a review article discussing the promise of hyperpolarised xenon MRI, a non-invasive ...

Fintel reports that on December 11, 2024, Citigroup downgraded their outlook for Pulmonx (NasdaqGS:LUNG) from Buy to Neutral.

Residents of Timișoara, in western Romania, can undergo free spirometry tests in a special tram as part of the ...

Growing population with respiratory diseases including chronic ailments is a key driver for the clinical demand ...

It was a busy week in the biotech sector with lots of data readouts. This apart, the key regulatory updates and pipeline news ...

Chronic obstructive pulmonary disease (COPD), a significant yet often overlooked health issue in Malaysia due to low awareness and understanding, affects a considerable portion of the population, as ...

The phase 1 clinical trial of APG333 is designed as a double-blind, placebo-controlled, first-in-human, single-ascending dose trial in healthy volunteers. It is expected to enroll approximately 32 ...

The holiday season is a time for joy, family and exciting celebrations. However, for those individuals living with chronic illnesses, managing their health during this time can be an added ...